GSC
GNCA

Ground Swell Capital’s Genocea Biosciences, Inc. GNCA Stock Holding History

Ground Swell Capital’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,616
Closed -$37K – 168
2021
Q1 		$37K Buy
+13,616
New +$40.3K 0.12% 90
2014
Q3 		$1K Sell
12
-25
-68% -$2.74K ﹤0.01% 2273
2014
Q2 		$6K Buy
+37
New +$5.61K 0.01% 1023

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Ground Swell Capital's GNCA Position: Q2 2021 in Review

Ground Swell Capital sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2021, closing a stake of 13,616 shares — an estimated $37K sold.

Ground Swell Capital first reported a position in GNCA in Q2 2014 and held it in 3 quarters. The position peaked at $37K in Q1 2021. 46 funds tracked by Wall St. Rank hold GNCA as of Q2 2021.

  • Ground Swell Capital reported no remaining Genocea Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ground Swell Capital sold 13,616 Genocea Biosciences, Inc. shares in Q2 2021, an estimated $37K.
  • Ground Swell Capital first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 3 quarters.
  • Ground Swell Capital's Genocea Biosciences, Inc. position peaked at $37K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2021.

Based on Ground Swell Capital's 13F filing for Q2 2021, filed 12 Aug 2021.